Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Liver Disease Diagnostics Market (By Technique: Laboratory tests, Imaging, Biopsy, Endoscopy, Others; By End Use: Hospitals & Clinics, Laboratories, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2028

Published : Apr 2021

Report ID: ARC2173

Pages : 190

Format : Liver Disease Diagnostics Market (By Technique: Laboratory tests, Imaging, Biopsy, Endoscopy, Others; By End Use: Hospitals & Clinics, Laboratories, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2028

CHAPTER 1.Industry Overview of Liver Disease Diagnostics

1.1.Definition and Scope 

1.1.1.Definition of Liver Disease Diagnostics

1.1.2.Market Segmentation

1.1.3.Years Considered for the Study

1.1.4.Assumptions and Acronyms Used

1.1.4.1.Market Assumptions and Market Forecast

1.1.4.2.Acronyms Used in Global Liver Disease Diagnostics Market

1.2.Summary

1.2.1.Executive Summary 

1.2.2.Liver Disease Diagnostics Market By Technique

1.2.3.Liver Disease Diagnostics Market By End Use

1.2.4.Liver Disease Diagnostics Market by Regions

CHAPTER 2.Research Approach

2.1.Methodology 

2.1.1.Research Programs

2.1.2.Market Size Estimation

2.1.3.Market Breakdown and Data Triangulation

2.2.Data Source

2.2.1.Secondary Sources

2.2.2.Primary Sources

CHAPTER 3.Market Dynamics And Competition Analysis

3.1.Market Drivers

3.1.1.Driver 1

3.1.2.Driver 2

3.2.Restraints and Challenges

3.2.1.Restrain 1

3.2.2.Restrain 2

3.3.Growth Opportunities

3.3.1.Opportunity 1

3.3.2.Opportunity 2 

3.4.Porter’s Five Forces Analysis

3.4.1.Bargaining Power of Suppliers

3.4.2.Bargaining Power of Buyers

3.4.3.Threat of Substitute

3.4.4.Threat of New Entrants

3.4.5.Degree of Competition

3.5.Market Concentration Ratio and Market Maturity Analysis of Liver Disease Diagnostics Market

3.5.1.Go To Market Strategy

3.5.1.1.Introduction

3.5.1.2.Growth

3.5.1.3.Maturity

3.5.1.4.Saturation

3.5.1.5.Possible Development

3.6.Technological Roadmap for Liver Disease Diagnostics Market

3.7.Value Chain Analysis

3.7.1.List of Key Manufacturers 

3.7.2.List of Customers

3.7.3.Level of Integration

3.8.Cost Structure Analysis

3.8.1.Price Trend of Key Raw Materials

3.8.2.Raw Material Suppliers

3.8.3.Proportion of Manufacturing Cost Structure

3.8.3.1.Raw Material

3.8.3.2.Labor Cost

3.8.3.3.Manufacturing Expense

3.9.Regulatory Compliance

3.10.Competitive Landscape, 2020

3.10.1.Player Positioning Analysis

3.10.2.Key Strategies Adopted By Leading Players

CHAPTER 4.Manufacturing Plant Analysis

4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020

4.2.R&D Status and Application Source of Liver Disease Diagnostics Major Manufacturers in 2020

CHAPTER 5.Liver Disease Diagnostics Market By Technique

5.1.Introduction

5.2.Liver Disease Diagnostics Revenue By Technique

5.2.1.Liver Disease Diagnostics Revenue (US$ Mn) and Forecast, By Technique, 2017-2028

5.2.2.Laboratory tests

5.2.2.1.Laboratory tests Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.3.Imaging

5.2.3.1.Imaging Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.4.Biopsy

5.2.4.1.Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.5.Endoscopy

5.2.5.1.Endoscopy Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.6.Others

5.2.6.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 6.Liver Disease Diagnostics Market Revenue By End Use

6.1.Introduction

6.2.Liver Disease Diagnostics Revenue (US$ Mn) By End Use

6.2.1.Liver Disease Diagnostics Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

6.2.2.Hospitals & Clinics

6.2.2.1.Hospitals & Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.3.Laboratories

6.2.3.1.Laboratories Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.4.Others

6.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 7.North America Liver Disease Diagnostics Market By Country 

7.1.North America Liver Disease Diagnostics Overview

7.2.U.S.

7.2.1.U.S. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028

7.2.2.U.S. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

7.3.Canada

7.3.1.Canada Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028

7.3.2.Canada Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

7.4.North America PEST Analysis

CHAPTER 8.Europe Liver Disease Diagnostics Market By Country

8.1.Europe Liver Disease Diagnostics Market Overview

8.2.U.K.

8.2.1.U.K. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028

8.2.2.U.K. Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

8.3.Germany

8.3.1.Germany Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028

8.3.2.Germany Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

8.4.France

8.4.1.France Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028

8.4.2.France Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

8.5.Spain

8.5.1.Spain Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028

8.5.2.Spain Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

8.6.Rest of Europe

8.6.1.Rest of Europe Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017-2028

8.6.2.Rest of Europe Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028

8.7.Europe PEST Analysis

CHAPTER 9.Asia Pacific Liver Disease Diagnostics Market By Country

9.1.Asia Pacific Liver Disease Diagnostics Market Overview

9.2.China

9.2.1.China Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

9.2.2.China Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

9.3.Japan

9.3.1.Japan Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

9.3.2.Japan Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

9.4.India

9.4.1.India Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

9.4.2.India Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

9.5.Australia

9.5.1.Australia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

9.5.2.Australia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

9.6.South Korea

9.6.1.South Korea Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

9.6.2.South Korea Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

9.7.Rest of Asia-Pacific

9.7.1.Rest of Asia-Pacific Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

9.7.2.Rest of Asia-Pacific Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

9.8.Asia Pacific PEST Analysis

CHAPTER 10.Latin America Liver Disease Diagnostics Market By Country

10.1.Latin America Liver Disease Diagnostics Market Overview

10.2.Brazil

10.2.1.Brazil Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

10.2.2.Brazil Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.3.Mexico

10.3.1.Mexico Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

10.3.2.Mexico Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

10.4.Rest of Latin America

10.4.1.Rest of Latin America Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 – 2028

10.4.2.Rest of Latin America Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

CHAPTER 11.Middle East & Africa Liver Disease Diagnostics Market By Country 

11.1.Middle East & Africa Liver Disease Diagnostics Market Overview

11.2.Saudi Arabia

11.2.1.Saudi Arabia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

11.2.2.Saudi Arabia Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

11.3.UAE

11.3.1.UAE Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

11.3.2.UAE Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

11.4.Rest of Middle East & Africa

11.4.1.Rest of Middle East & Africa Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By Technique, 2017 - 2028

11.4.2.Rest of Middle East & Africa Liver Disease Diagnostics Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028

CHAPTER 12.Player Analysis Of Liver Disease Diagnostics

12.1.Liver Disease Diagnostics Market Company Share Analysis

12.2.Competition Matrix

12.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2.New Product Launches and Product Enhancements

12.2.3.Mergers And Acquisition In Global Liver Disease Diagnostics Market

12.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13.COMPANY PROFILE

13.1.AstraZeneca

13.1.1.Company Snapshot

13.1.2.Business Overview

13.1.3.Financial Overview

13.1.3.1.Revenue (US$ Mn), 2020

13.1.3.2.AstraZeneca 2020 Liver Disease Diagnostics Business Regional Distribution

13.1.4.Product/ Service and Specification

13.1.5.Recent Developments & Business Strategy

13.1.6.Manufacturing Plant Footprint Analysis

13.2.Bayer AG

13.3.Gilead Science Inc. 

13.4.Merck & Co. Inc

13.5.F. Hoffmann-La Roche AG

13.6.Sanofi

13.7.Pfizer Inc.

13.8.Novartis AG

13.9.GlaxoSmithKline plc

13.10.Others

Frequently Asked Questions

What will be the market value of Liver Disease Diagnostics in 2028?

The Liver Disease Diagnostics market value is anticipated to be worth around US$ 38.9 Bn in 2028.

What will be the CAGR of Liver Disease Diagnostics market?

The Liver Disease Diagnostics market is anticipated to grow around 6.1% CAGR amid the forecast period 2021-2028.

Which region held highest share in 2019 in the global Liver Disease Diagnostics market?

North America held highest market share in 2019.

Which region is projected to be the fastest growing region in the global Liver Disease Diagnostics market?

Asia Pacific is projected to be the fastest growing region in the global market

Which are the prominent players in the Liver Disease Diagnostics market?

AstraZeneca, Bayer AG, Gilead Science Inc., Merck & Co. Inc, F. Hoffmann-La Roche AG, Sanofi, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, and Others are the prominent players in the Liver Disease Diagnostics market.

Which insight provides on the Liver Disease Diagnostics market?

The report provides insights on global Liver Disease Diagnostics market segment by technique, by end use and major geographic regions.

What is the key factor driving the Liver Disease Diagnostics market?

global liver diagnostic is the rising prevalence of acute and chronic liver diseases. The development of reliable diagnostic tools in order to enhance early detection and patient care outcomes will accelerate research and development by key industry players and will further fuel profit growth on this global market.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research and Consulting

100%

Customer Satisfaction

24x7+

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date